Carol Ann Vanderwal

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors

Anthony W. Tolcher, Patricia LoRusso, Jennifer A. Arzt et al. · Cancer Chemotherapy and Pharmacology · 2015 · 66 citations

Medicine, Oncology, Pharmacokinetics +11

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study

Anthony W. Tolcher, Patricia LoRusso, Jennifer A. Arzt et al. · Cancer Chemotherapy and Pharmacology · 2015 · 38 citations

Medicine, Pharmacokinetics, Pharmacology +10

A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFR

James M. Cleary, Emiliano Calvo, Víctor Moreno et al. · Investigational New Drugs · 2020 · 31 citations

Medicine, Oncology, Pharmacokinetics +17